Armando Anido

Type: Person
Name: Armando Anido
First reported Jan 21 2014 - Updated Jan 22 2014 - 1 reports

NuPathe Picks Teva as Merger Partner

NEW YORK (The Deal) -- Teva Pharmaceutical Industries won a bid to purchase Malvern, Pa.-based NuPathe with an offer that came in at only $9 million more than its M&A rival, Endo Health Solutions . NuPathe said Tuesday it entered into an agreement ... [Published The Street Latest - Jan 21 2014]
First reported Dec 18 2013 - Updated Dec 18 2013 - 1 reports

Endo to buy specialty pharma company NuPathe for $105 million

Endo Health Solutions, a US-based specialty healthcare company, has entered into a definitive agreement under which Endo will acquire NuPathe Inc. for $2.85 per share in cash, or approximately $105 million. In addition to the upfront cash payment, NuPathe ... [Published PharmaBiz - Dec 18 2013]

Quotes

Teva is "a recognized leader in the field of diseases of the central nervous system," NuPathe CEO Armando Anido said in a statement. "we believe that teva is well-positioned to maximize zecuity's potential."

More Content

All (2) | News (2) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NuPathe Picks Teva as Merger Partner [Published The Street Latest - Jan 21 2014]
Endo to buy specialty pharma company NuPathe fo... [Published PharmaBiz - Dec 18 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.